Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

GRAM publications

Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.

GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655

Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.

GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418

The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.

Antimicrobial Resistance Collaborators None., (2024), Lancet Glob Health, 12, e201 - e216

The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.

Antimicrobial Resistance Collaborators None., (2023), Lancet Reg Health Am, 25

Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.

GBD 2019 Antimicrobial Resistance Collaborators None., (2022), Lancet, 400, 2221 - 2248

The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.

European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913

Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.

Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681

Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.

Browne AJ. et al, (2021), Lancet Planet Health

The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.

Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101

Recent publications by Researchers affiliated with the GRAM project

Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.

Poolchanuan P. et al, (2025), Sci Rep, 15

Combined effects of hydrological conditions and socioeconomic factors on the seasonal dynamics of severe fever with thrombocytopenia syndrome in China, 2011–2022: a modelling study

Ge HH. et al, (2025), The Lancet Regional Health - Western Pacific, 58

Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis.

Yilma D. et al, (2025), Lancet Infect Dis

Patient-reported harm from NHS treatment or care, or the lack of access to care: a cross-sectional survey of general population prevalence, impact and responses.

Crocker H. et al, (2025), BMJ Qual Saf

History of scrub typhus in Indonesia.

Saraswati K. et al, (2025), Trans R Soc Trop Med Hyg, 119, 338 - 345

Mapping the global distribution of and environmental suitability for scrub typhus

Maude R. et al, (2025)

Combining demographic shifts with age-based resistance prevalence: a modelling estimate of future AMR burden in Europe and implications for targets

Waterlow NR. et al, (2025)

Understanding the primary healthcare context in rural South and Southeast Asia: a village profiling study.

Chew R. et al, (2025), Int Health

Comparing HemoCue® and Quantitative Buffy Coat® and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.

Ayuen DS. et al, (2025), Malar J, 24

Recurrence of microfilaraemia after triple-drug therapy for lymphatic filariasis in Samoa: Recrudescence or reinfection?

Mayfield HJ. et al, (2025), Int J Infect Dis, 152

Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.

Watson JA. et al, (2025), Antimicrob Agents Chemother

Protocol for the process evaluation for a cluster randomised controlled trial evaluating primary school-based screening and intervention delivery for childhood anxiety problems.

Williamson V. et al, (2025), BMJ Open, 15

Advancing artemisinin resistance monitoring using a high sensitivity ddPCR assay for Pfkelch13 mutation detection in Asia.

Srisutham S. et al, (2025), Sci Rep, 15

Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV).

Jittamala P. et al, (2025), EClinicalMedicine, 80

Sustainable antimicrobial resistance surveillance: time for a global funding mechanism.

Painter C. et al, (2025), Lancet Infect Dis, 25, e99 - e103

Experiences, perceptions and ethical considerations of the malaria infection study in Thailand.

Naemiratch B. et al, (2025), BMC Med Ethics, 26

Integrated Serosurveillance of Infectious Diseases Using Multiplex Bead Assays: A Systematic Review.

Ward S. et al, (2025), Trop Med Infect Dis, 10

Community responses to a novel house design: A qualitative study of "Star Homes" in Mtwara, southeastern Tanzania.

Mshamu S. et al, (2025), PLoS One, 20

Leptospirosis, melioidosis, and rickettsioses in the vicious circle of neglect.

Tshokey T. et al, (2025), PLoS Negl Trop Dis, 19

Bringing the real world into the classroom through team-based live brief projects

Jackson J. et al, (2024), Approaches to Work-Based Learning in Higher Education: Improving Graduate Employability, 81 - 105

Load More